Company intelligence / Profile preview

Wellcome Leap

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Wellcome Leap funds and operates a portfolio of ambitious, accelerated programs in global health and biomedical science, aiming for transformative breakthroughs in as little as 5–10 years, building on a DARPA-inspired innovation model. Their programs have advanced fields ranging from pandemic vaccine manufacturing to infant neurodevelopment and healthy aging, and have launched multi-country collaborations producing early technological and biological insights[1][2][3][6][7].

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesCardiovascularOncologyNeurology
Modalities: mRNA-based drugsRNA therapyBiologicVaccineDevice
Industry: Investors

Partnerships

Leap Health Breakthrough Network (over 150 global academic and research organizations)[2][3]

Beyond the preview

Go deeper on Wellcome Leap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wellcome Leap.

Explore the full profile